1486 related articles for article (PubMed ID: 8975785)
21. Dual effects of phloretin on aflatoxin B1 metabolism: activation and detoxification of aflatoxin B1.
Gao SS; Chen XY; Zhu RZ; Choi BM; Kim SJ; Kim BR
Biofactors; 2012; 38(1):34-43. PubMed ID: 22253071
[TBL] [Abstract][Full Text] [Related]
22. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.
Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP
Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634
[TBL] [Abstract][Full Text] [Related]
23. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
24. Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system.
Salmela KS; Kessova IG; Tsyrlov IB; Lieber CS
Alcohol Clin Exp Res; 1998 Dec; 22(9):2125-32. PubMed ID: 9884161
[TBL] [Abstract][Full Text] [Related]
25. 2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes.
Ch'ih JJ; Biedrzycka DW; Lin T; Khoo MO; Devlin TM
Proc Soc Exp Biol Med; 1989 Oct; 192(1):35-42. PubMed ID: 2508094
[TBL] [Abstract][Full Text] [Related]
26. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
27. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
28. In vitro biotransformation of aflatoxin B1 (AFB1) in channel catfish liver.
Gallagher EP; Eaton DL
Toxicol Appl Pharmacol; 1995 May; 132(1):82-90. PubMed ID: 7747288
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 enzymes involved in the metabolism of aflatoxin B1 in chickens and quail.
Diaz GJ; Murcia HW; Cepeda SM
Poult Sci; 2010 Nov; 89(11):2461-9. PubMed ID: 20952710
[TBL] [Abstract][Full Text] [Related]
30. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
[TBL] [Abstract][Full Text] [Related]
31. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms.
Eaton DL; Bammler TK; Kelly EJ
Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.
Langouët S; Coles B; Morel F; Becquemont L; Beaune P; Guengerich FP; Ketterer B; Guillouzo A
Cancer Res; 1995 Dec; 55(23):5574-9. PubMed ID: 7585637
[TBL] [Abstract][Full Text] [Related]
33. In vitro prostaglandin H synthase- and monooxygenase-mediated binding of aflatoxin B1 to DNA in guinea-pig tissue microsomes.
Liu L; Daniels JM; Stewart RK; Massey TE
Carcinogenesis; 1990 Nov; 11(11):1915-9. PubMed ID: 2121380
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites.
Oda Y; Kharasch ED
J Pharmacol Exp Ther; 2001 Apr; 297(1):410-22. PubMed ID: 11259570
[TBL] [Abstract][Full Text] [Related]
35. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
Choi CY; Park SH; Park EH; Cha YN
J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
[TBL] [Abstract][Full Text] [Related]
36. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
[TBL] [Abstract][Full Text] [Related]
37. Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes.
Kim BR; Kim DH; Park R; Kwon KB; Ryu DG; Kim YC; Kim NY; Jeong S; Kang BK; Kim KS
Planta Med; 2001 Jul; 67(5):396-9. PubMed ID: 11488450
[TBL] [Abstract][Full Text] [Related]
38. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
40. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
